Aadi Bioscience, Inc. (AADI) Misses Q1 EPS by 5c

Aadi Bioscience, Inc. (NASDAQ: AADI) reported Q1 EPS of ($0.68), $0.05 worse than the analyst estimate of ($0.63). Revenue for the quarter came in at $5.4 million versus the consensus estimate of $6.5 million.

For earnings history and earnings-related data on Aadi Bioscience, Inc. (AADI) click here.

You May Also Be Interested In

• Synopsys upgraded at Piper Sandler on Intel foundry momentum, Apple opportunity
• Primoris cuts 2026 outlook on renewables cost overruns, COO exits
• Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance